| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,121 |
20,341 |
$2.05M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,663 |
5,484 |
$532K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
493 |
446 |
$58K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,104 |
3,952 |
$52K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,454 |
3,273 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,658 |
1,591 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,110 |
3,918 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,058 |
2,234 |
$17K |
| 81002 |
|
605 |
579 |
$6K |
| 99000 |
|
3,398 |
3,236 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
13 |
$880.00 |
| S8301 |
Infection control supplies, not otherwise specified |
4,460 |
4,238 |
$690.00 |
| 87807 |
|
249 |
231 |
$601.31 |
| 71046 |
Radiologic examination, chest; 2 views |
40 |
37 |
$352.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,344 |
1,297 |
$100.00 |
| 99050 |
|
333 |
327 |
$29.88 |
| 99001 |
|
440 |
420 |
$12.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
967 |
936 |
$0.26 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
11,603 |
10,965 |
$0.08 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,387 |
4,217 |
$0.00 |
| 94760 |
|
5,643 |
5,093 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,539 |
3,402 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
7,352 |
6,925 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
537 |
519 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
767 |
723 |
$0.00 |
| G8756 |
No documentation of blood pressure measurement, reason not given |
6,486 |
6,173 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
860 |
838 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
3,342 |
3,208 |
$0.00 |
| 1036F |
|
37 |
33 |
$0.00 |
| 3008F |
|
1,459 |
1,346 |
$0.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
12 |
12 |
$0.00 |
| 36416 |
|
542 |
493 |
$0.00 |
| 99051 |
|
3,600 |
3,331 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
630 |
597 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
4,538 |
4,297 |
$0.00 |
| S5000 |
Prescription drug, generic |
650 |
616 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
7,197 |
6,793 |
$0.00 |
| 99072 |
|
1,189 |
1,143 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
372 |
351 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
496 |
460 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
1,441 |
1,328 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
733 |
699 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
744 |
710 |
$0.00 |
| 74018 |
|
12 |
12 |
$0.00 |